Envafolimab combined with lenvatinib and albumin-bound paclitaxel in previously treated advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: a prospective, phase II, multi-cohort trial

Abstract Background This single-center, open-label, exploratory trial aimed to investigate the efficacy and safety of envafolimab combined with lenvatinib and chemotherapy in previous treated advanced G/GEJ adenocarcinoma. Methods Eligible patients with HER2-negative, microsatellite stable (MSS) adv...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Zhao Xiaoying, Feng Wanjing, Geng Qirong, Huang Mingzhu, Zhang Zhe, Chen Jinsi, Sheng Xuedan, Zhu Xiaodong, Guo Weijian
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Springer 2026-04-01
سلاسل:	Cancer Immunology, Immunotherapy
الموضوعات:	Gastric/gastroesophageal junction Albumin-bound paclitaxel Envafolimab
الوصول للمادة أونلاين:	https://doi.org/10.1007/s00262-026-04373-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!